Chau Q. Khuong   |   Director

Chau Quang Khuong is Partner in the Private Equity group at OrbiMed Advisors, a global healthcare-dedicated investment firm with approximately $15 billion in assets under management. Mr. Khuong has been an active investor in innovative drug development and medical device enterprises across all stages and numerous therapeutic/technology areas including oncology, infectious diseases, gene editing, and ophthalmology. He currently serves as a Board director of numerous public and private companies, including Greybug Vision, Immatics GmbH, Inspire Medical Systems, Intellia, Nabriva (NASDAQ: NBVR), Otonomy, Inc. (NASDAQ: OTIC), Pieris Pharmaceuticals (NASDAQ: PIRS), ReViral Ltd, and Synlogic. He holds a B.S. in molecular, cellular and developmental biology with concentration in biotechnology and an M.P.H. with concentration in infectious diseases, both from Yale University. • David Kabakoff, Ph.D.
Chairman
• Elaine V. Jones, Ph.D.
Director
• Chau Q. Khuong
Director
• Judith J. Li
Director
• Tim Shannon, M.D.
Director